Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Public comment period · §3

Draft synthesis: Gastrointestinal adverse events with… — disposition

The disposition of every submission and the amendments that resulted.

Document identifier
CEI-CP-100/3
Series
Public comment period
Version
1.0
Published
29 Mar 2025
Last reviewed
29 Mar 2025
Next review
29 Mar 2026
Identifier
10.71829/cei.cp.100
Certainty
Not rated
Cycle
2025 Q1
Window
24 Jan 2025 – 21 Feb 2025
Status
Closed
Submissions
12

§3Disposition and amendments

§3.1Disposition table

Table 1. Every submission with its disposition. Each row links to the submission in full.

ReferenceRespondentPoint raisedDisposition
DRAFT-GASTROINTEST/006Xenia Nyquist-Obiora industryA sponsor trial meeting the eligibility criteria was excludedAccepted in part
DRAFT-GASTROINTEST/003Dr Wilhelmina ErlingssonReferences should carry a persistent identifier for every cited sourceAccepted in part
DRAFT-GASTROINTEST/008Dr Oisín Marchetti-Bassey industryThe document should not describe uses outside the approved indicationNot accepted
DRAFT-GASTROINTEST/005Dr Rurik Underhill-Okafor industryTwo factual descriptions of the sponsor's programme are inaccurateAccepted
DRAFT-GASTROINTEST/002Dr Rosalind Grünbaum-SowandePoint estimates are given without an intervalAccepted in part
DRAFT-GASTROINTEST/009Dr Eamon ImmelmannThe same concept is given three different names in one documentAccepted
DRAFT-GASTROINTEST/007Dr Rurik Haverkamp-DialloThe search strategy as published cannot be re-runAccepted
DRAFT-GASTROINTEST/012Dr Eamon ImmelmannThe document set should be published in translationNot accepted
DRAFT-GASTROINTEST/001Ignatius ErlingssonThe search date is not on the face of the documentAccepted
DRAFT-GASTROINTEST/010Dr Liesbeth Zaleski-MbekiRisk-of-bias judgements are reported as an overall rating without the domainsAccepted
DRAFT-GASTROINTEST/004Dr Adaeze Dunmore-EkpoThe review protocol is described but its registration record is not linkedAccepted in part
DRAFT-GASTROINTEST/011Dr Liesbeth Zaleski-MbekiEfficacy outcomes are rated for certainty and harms are notAccepted
12 submissions in total.

§3.2Summary by disposition

Table 2. Counts by disposition, with the meaning of each.

DispositionCountMeaning
Accepted6The submission is accepted and the draft is amended as proposed. The amendment is recorded in the amendment log of the document it changed and is traceable to the numbered submission.
Accepted in part4Part of the submission is accepted and part is not. The secretariat response states which part is which and on what ground the remainder was declined.
Noted, no amendment0The submission raises a point the Institute accepts but that does not require a change to the draft, most often because the draft already states it elsewhere. The location is given in the response.
Not accepted2The submission is not accepted. The secretariat response gives the reason. A submission that is not accepted remains published in full; the Institute does not remove a submission because it disagrees with it.

§3.3Resulting amendments

  1. A sponsor trial meeting the eligibility criteria was excluded — arising from DRAFT-GASTROINTEST/006. The trial is added to the included set, the estimate and the certainty rating have been recomputed, and the screening record now states why the trial was missed, which was a database indexing gap rather than a screening judgement. The submission is identified…
  2. References should carry a persistent identifier for every cited source — arising from DRAFT-GASTROINTEST/003. Every reference without a persistent identifier now carries an explicit statement that the identifier is not held by the Institute, so that its absence is a recorded fact rather than an apparent oversight.
  3. Two factual descriptions of the sponsor's programme are inaccurate — arising from DRAFT-GASTROINTEST/005. The trial status now reads as completed at a pre-specified interim analysis, with the analysis identified, and the dose is stated in the unit used in the approved labelling. The submission is identified as an industry submission on its face in accordance with…
  4. Point estimates are given without an interval — arising from DRAFT-GASTROINTEST/002. Every estimate now carries its interval where the source reported one, and where it did not, the estimate is annotated as reported without an interval rather than left to appear as a precise figure.
  5. The same concept is given three different names in one document — arising from DRAFT-GASTROINTEST/009. A single term is now used throughout for each defined concept, and the glossary entry is linked at first use within each section rather than once per document.
  6. The search strategy as published cannot be re-run — arising from DRAFT-GASTROINTEST/007. The full line-by-line strategy for each database is now published with the interface, the run date and the yield at each line, and the total retrieved is reconciled against the screening flow.
  7. The search date is not on the face of the document — arising from DRAFT-GASTROINTEST/001. The search date is now printed adjacent to every certainty rating and is carried in the document metadata, so that the interval between the search and the reading is visible without reference to the methods section.
  8. Risk-of-bias judgements are reported as an overall rating without the domains — arising from DRAFT-GASTROINTEST/010. Risk of bias is now reported at domain level for every included study, with the text on which each judgement was based quoted and referenced, and the overall judgement derived from the domains rather than asserted alongside them.
  9. The review protocol is described but its registration record is not linked — arising from DRAFT-GASTROINTEST/004. Each synthesis now links its own protocol with the version in force at screening, and states explicitly where an external registration identifier is not held, so that the absence is a recorded fact.
  10. Efficacy outcomes are rated for certainty and harms are not — arising from DRAFT-GASTROINTEST/011. Every reported harm now carries a certainty rating on the same scale as the efficacy outcomes, with the downgrade reasons stated, and discontinuation for adverse events appears in the summary of findings rather than in an annex.

References cited on this page

References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.

  1. International Organization for Standardization. ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories. ISO/IEC Standard 2017;3rd edition. identifier not held by the Institute

Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.